Learn More
Medchemexpress LLC Atazanavir sulfate | 229975-97-7 | 99.7% | 802.93 | 5 MG

Supplier: Medchemexpress LLC HY173675MG
Atazanavir (BMS-232632) sulfate is a highly selective and orally active HIV-1 protease inhibitor with blood-brain barrier permeability. Atazanavir sulfate is a substrate and inhibitor of CYP3A4, and an inhibitor of P-glycoprotein (P-gp). Atazanavir sulfate is also a SARS-CoV 3CLpro inhibitor with an IC50 of 3.49 μM. Atazanavir sulfate inhibits cardiac fibrosis, hyperlipidemia and induces malignant glioma death.
- Highly selective and orally active HIV-1 protease inhibitor with blood-brain barrier permeability.
- Functions as a substrate and inhibitor of CYP3A4.
- Acts as an inhibitor of P-glycoprotein (P-gp).
- Inhibits SARS-CoV 3CLpro with an IC50 of 3.49 μM.
- Inhibits cardiac fibrosis.
- Inhibits hyperlipidemia.
- Induces malignant glioma death.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.